First Interstate Bank’s Charles River Laboratories CRL Stock Holding History

First Interstate Bank’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-83	Closed	-$12K	–	641
2019 Q1	$12K	Hold	83	–	–	﹤0.01%	544
2018 Q4	$9K	Sell	83 -232	-74%	-$29K	﹤0.01%	549
2018 Q3	$42K	Buy	+315	New	+$38.9K	0.01%	380

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

First Interstate Bank's CRL Position: Q2 2019 in Review

First Interstate Bank sold out of Charles River Laboratories (CRL) in Q2 2019, closing a stake of 83 shares — an estimated $12K sold.

First Interstate Bank first reported a position in CRL in Q3 2018 and held it in 3 quarters. The position peaked at $42K in Q3 2018. 405 funds tracked by Wall St. Rank hold CRL as of Q2 2019.

First Interstate Bank reported no remaining Charles River Laboratories position as of Q2 2019 after selling out during the quarter.
First Interstate Bank sold 83 Charles River Laboratories shares in Q2 2019, an estimated $12K.
First Interstate Bank first reported a position in Charles River Laboratories in Q3 2018 and held it in 3 quarters.
First Interstate Bank's Charles River Laboratories position peaked at $42K in Q3 2018.
405 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2019.

Based on First Interstate Bank's 13F filing for Q2 2019, filed 5 Aug 2019.